Studies will use BreathID 13 C-methacetin breath test to evaluate patient response to therapy MODI’IN, Israel and MANASQUAN, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE:EXEN) ...
Building on the BreathID Hp urea breath testing technology for Helicobacter pylori (H. pylori) detection, the new BreathID Hp Lab system provides cost-effective automated batch test analysis for ...
Approximately two-thirds of the world's population and 30 percent to 40 percent of the U.S. population are infected with Helicobacter pylori bacteria. The World Health Organization classifies H.
Exalenz Bioscience (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new ...
Exalenz Biosciences announced a collaboration with Conatus Pharmaceuticals. The deal will find Conatus using the BreathID Methacetin Breath Test (MBT) to monitor patients in a Phase IIb clinical trial ...
Exalenz Bioscience has launched a clinical trial that will evaluate BreathID, a diagnostic test that could potentially diagnose nonalcoholic steatohepatitis, according to a press release. The trial ...
TEL AVIV (Reuters) - Exalenz Bioscience, a developer of diagnostic systems that use a patient's breath to detect gastrointestinal and liver conditions, launched BreathID Hp, a next generation device ...
We are not yet done with electronic noses for today. The Jerusalem Post is reporting that an instrument manufactured by Oridion Systems Ltd. can noninvasively determine whether a patient has hepatitis ...
Exalenz Bioscience (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced a ...
JERSEY CITY, N.J., July 23, 2013 /PRNewswire/ -- Exalenz Bioscience (TASE: EXEN), developer of advanced diagnostic systems that use a patient's breath to detect and help manage gastrointestinal and ...
Exalenz Bioscience’s flagship product is the BreathID® Hp test, a non-invasive urea in-office breath test designed to detect active H. pylori infections within minutes. Clinical studies have ...